Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 14, 2019

SELL
$2.0 - $2.65 $664,112 - $879,948
-332,056 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$2.08 - $3.36 $61,499 - $99,345
29,567 Added 9.77%
332,056 $764,000
Q3 2018

Nov 14, 2018

SELL
$2.6 - $3.59 $643,528 - $888,564
-247,511 Reduced 45.0%
302,489 $971,000
Q2 2018

Aug 14, 2018

SELL
$2.83 - $4.11 $97,813 - $142,053
-34,563 Reduced 5.91%
550,000 $1.56 Million
Q1 2018

May 14, 2018

SELL
$3.54 - $4.54 $70,800 - $90,800
-20,000 Reduced 3.31%
584,563 $0
Q4 2017

Feb 14, 2018

BUY
$3.23 - $4.3 $1.95 Million - $2.6 Million
604,563
604,563 $0

Others Institutions Holding RIGL

About RIGEL PHARMACEUTICALS INC


  • Ticker RIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 172,836,000
  • Market Cap $2.84B
  • Description
  • Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...
More about RIGL
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.